Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

The purpose of this investigation was to assess the real-life effectiveness of pegylated interferon (peg-IFN) α-2b with ribavirin (RBV) in a cohort of treatment-naïve patients with chronic genotypes 2 (G2) or 3 (G3) hepatitis C virus (HCV) infection. A post-hoc pooled analysis of two Canadian multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Marotta, P., Bailey, R., Elkashab, M., Farley, J., Feinman, S. V., Peltekian, K., Poliquin, M., Witt-Sullivan, H., Rampakakis, E., Drolet, M., Cooper, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819461/
https://www.ncbi.nlm.nih.gov/pubmed/26851949
http://dx.doi.org/10.1007/s10096-016-2576-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819461/
https://www.ncbi.nlm.nih.gov/pubmed/26851949
http://dx.doi.org/10.1007/s10096-016-2576-1

Ejemplares similares